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Abstract
Polymorphism at the GPSM3 gene locus is inversely associated with four systemic autoimmune
diseases, including rheumatoid arthritis and ankylosing spondylitis. G-protein signaling
modulator-3 (GPSM3) expression is most pronounced in myeloid cells, in which it targets
heterotrimeric G-protein Gαi subunits of chemokine receptors, critical to immune function. To
begin to explore the regulatory role of GPSM3 in monocytes, human THP-1 and primary mouse
myeloid cells were cultured under stimulus conditions; GPSM3 was found by immunoblotting to
be expressed at highest levels in the mature monocyte. To evaluate the effects of GPSM3
deficiency on a myeloid-dependent autoimmune disease, Collagen Antibody-Induced Arthritis
(CAIA) was induced in Gpsm3−/− and control mice, which were then analyzed for clinical score,
paw swelling, intra-articular proinflammatory markers, and histopathology. Mice lacking GPSM3
were protected from CAIA, and expression of monocyte-representative pro-inflammatory
chemokine receptors and cytokines in paws of Gpsm3−/− mice were decreased. Flow cytometry,
apoptosis, and transwell chemotaxis experiments were conducted to further characterize the effect
of GPSM3 deficiency on survival and chemokine responsiveness of monocytes. GPSM3-deficient
myeloid cells had reduced migration ex vivo to CCL2, CX3CL1, and chemerin and enhanced
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apoptosis in vitro. Our results suggest that GPSM3 is an important regulator of monocyte function
involving mechanisms of differentiation, survival, and chemotaxis, and deficiency in GPSM3
expression is protective in acute inflammatory arthritis.
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rheumatoid arthritis
1. Introduction
Myeloid derived cells such as monocytes and macrophages represent a major first line of
defense against pathogens, but also contribute substantially to the pathogenesis of aseptic
conditions such as chronic autoinflammatory and autoimmune disease (1, 2). Cytokines
secreted by monocytes/macrophages comprise a diverse group of molecules including
interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α),
interleukin-23 (IL-23), and interferon-γ (IFN-γ), all of which are involved in autoimmune
pathogenesis (2, 3) and have been targeted effectively for the treatment of autoimmune
disease (4).
G protein-coupled receptors (GPCRs) expressed on monocytes and macrophages regulate a
variety of functions, including cell-to-cell contacts, cell activation and survival decisions,
inflammatory mediator production, and chemotaxis (5). The intracellular signals transduced
by cell-surface GPCRs are tightly controlled by a guanine nucleotide-binding complex of
Gα, Gβ, and Gγ subunits, as well as a growing array of regulatory and accessory proteins
(6). Consequently, this family of receptors has been extensively studied and exploited as
drug discovery targets to identify valuable modulators of the immune response.
We and others have identified a novel set of regulators of G-protein signaling (6) involving
association between inactive GDP-bound Gαi/o subunits and GoLoco motifs. Among the
GoLoco class of proteins, one of the smallest called GPSM3 (‘G-protein signaling
modulator-3’; a.k.a. AGS4 or G18) is known to bind not only to Gαi·GDP subunits but also
to free Gβ subunits during their biosynthetic path towards Gβγ dimer formation (6). Gene
atlas data of the human transcriptome demonstrates that GPSM3 mRNA has restricted tissue
expression to hematopoietic organs with highest expression in myeloid cells (Fig. S1A),
suggesting a potential role in immune regulatory responses. Additionally, GPSM3 mRNA
was recently shown to decrease in the paw after anti-inflammatory treatment with
dexamethasone in the Collagen Induced Arthritis (CIA) model (7), supporting a potential
role for GPSM3 in inflammatory arthritis.
Recently, polymorphisms within the human GPSM3 gene locus (SNPs rs204989 and
rs204991) were identified in GWAS studies (8, 9) as being significantly less prevalent in
multiple autoimmune diseases, including rheumatoid arthritis (RA) and ankylosing
spondylitis (AS). Based on the prominent expression of GPSM3 in myeloid cells and its
regulatory implications in CIA, we chose to examine functional responses of wildtype and
GPSM3-deficient mice in the Collagen Antibody-Induced Arthritis (CAIA) model, known to
be highly dependent on monocyte function and innate immune responses (10). In vitro and
ex vivo data suggest GPSM3 is an important regulator of monocyte function involving, at
least in part, regulation of differentiation, chemotaxis, and survival, and its deficiency is
protective in acute inflammatory arthritis.
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2. MATERIALS AND METHODS
2.1. Reagents, cell culture, and microscopy
Monoclonal antibody against CD14 (clone rmC5-3) was from BD Pharmingen (San Diego).
Anti-GPSM3 antibody was produced as described (6). Chemokines were from PeproTech
(Rocky Hill, NJ). Cell lines were from American Type Culture Collection, grown in RPMI
1640 or DMEM (L-929) and supplemented with 10% FBS (Cellgro, Manassas, VA). THP-1
cells were transduced with control or GPSM3-silencing shRNA (sh19 or sh20), selected in
2.5 μg/ml puromycin, and confirmed for GPSM3 knockdown by immunoblot. Imaging of
GPSM3 was performed as previously described (6).
2.2. CAIA arthritis model
All work was performed using IACUC-approved protocols in the AAALAC-accredited
vivarium of UNC. Gpsm3-deficient (−/−) mice were obtained by breeding heterozygous
C57Bl/6 mice purchased from the Texas Institute for Genomic Medicine. Parental mice
were obtained by knocking out one copy of Gpsm3 via gene-trap insertion in C57Bl/6N ES
cells (Fig. S2A). For CAIA, mice were injected on day 0 intraperitoneally with a cocktail of
5 anti-collagen monoclonals (5 mg/0.5 ml/mouse; Chondrex) and on day 3 with LPS (50 μg/
0.1 ml/mouse). Mice were monitored daily for arthritis severity by a blinded observer as
described (11, 12). Hind paws were isolated and fixed for 24h in Tellyesnickzky/Fekete
fixative, decalcified using formic acid, and embedded in paraffin. Serial 5–7 μm sections
were stained with H&E and analyzed by a blinded veterinary pathologist.
2.3. Quantitative real-time PCR
Joint tissues or cells were harvested at experiment termination. Expression of intra-articular
mRNAs was measured by qRT-PCR using validated primers as previously described (11).
2.4. Chemotaxis
Chemotaxis experiments were performed as described (12) on Ly6C-enriched splenocytes.
Briefly, mouse spleens were manually disrupted and filtered through 70 μm mesh, RBCs
lysed, and enriched for Ly6C+ cells by magnetic separation using anti-Ly6C-biotin beads
(Miltenyi Biotec, MA). Staining and flow cytometry analysis of migrated cells from the
lower chambers was performed using anti-CD11b (eBioscience).
2.5. Flow cytometry
One million splenocytes were stained and analyzed using a Beckman-Coulter (Dako) CyAn
ADP Analyzer. Anti-Ly6C-FITC and anti-Ly6G-PE were from eBioscience and anti-CCR2-
APC was from R&D Systems.
2.6. Apoptosis
THP-1 cells were transduced with control or GPSM3-silencing shRNA as described (6). To
induce apoptosis, 4–5 × 105 THP-1 cells were plated for 20h in culture media with or
without 10 μM etoposide (Trevigen, Gaithersburg, MD). Cells were harvested, washed,
stained with FITC-annexin V and propidium iodide using the TACS Annexin-V FITC kit
(Trevigen), and analyzed by flow cytometry using a CyAn ADP Analyzer. Data is expressed
as fold-increase in apoptotic cells between untreated and etoposide-treated matched samples.
2.7. Statistical analyses
For clinical disease and paw swelling, linear mixed models were used as described (11). The
overall group effect was assessed using a likelihood ratio test (LRT) (α=.05) with SAS v9.2.
Giguère et al. Page 3













For qRT-PCR, flow cytometry, and chemotaxis data, a two tailed Student’s t test was used
and, for histopathology scores, a Mann-Whitney U test was used with Prism v4.
3. RESULTS
3.1. GPSM3 protein levels are highest in mature monocytes
Based on the mRNA expression profile of GPSM3 within the human transcriptome (Fig.
S1A), we hypothesized that GPSM3 protein expression may be restricted to the
hematopoietic lineage with significant expression in monocytes. First, we screened
immortalized human cell lines for endogenous GPSM3 expression using an antibody against
human and mouse GPSM3 (6). A weak but specific signal at the expected GPSM3
molecular weight of 18 kDa was detected in lysates from human cell lines derived from
acute lymphoblastic leukemia (Molt4), T cell leukemia (Jurkat), and Burkitt’s lymphoma
(Ramos), but not in cells lines of non-hematopoietic origin (HEK293, BE2C, SH-SY5Y)
(Fig. S1B). In contrast, strong expression was seen in the acute monocytic leukemia cell line
THP-1 (Fig. S1B). To further confirm these data in primary cells, bone marrow from C57Bl/
6 mice was differentiated using macrophage colony-stimulating factor (M-CSF) (13).
Upregulation of CD14, a marker of the monocyte/macrophage lineage (14), increased
coincident with levels of GPSM3 during differentiation (Fig. 1A).
To determine whether GPSM3 expression might be altered following activation, we
differentiated the monocytic THP-1 cell line into macrophage-like cells using phorbol 12-
myristate 13-acetate (PMA) treatment (15). PMA treatment over 72 hours decreased
GPSM3 protein levels (Fig. 1B) and GPSM3 mRNA levels (Fig. 1C). Decreased GPSM3
expression was also observed by indirect immunofluorescence and confocal microscopy.
Untreated THP-1 cells exhibited robust expression of endogenous GPSM3 that localized to
the plasma membrane; PMA treatment led to decreased GPSM3 immunostaining with more
differentiated cells (identified by their macrophage-like, spreading morphology) showing the
least GPSM3 expression (Fig. 1D).
3.2. Gpsm3−/− mice are protected from CAIA
Because mature monocytes expressed the highest GPSM3 protein levels, we hypothesized
that differential GPSM3 expression in monocytes might affect inflammatory disease in
mice. Gpsm3−/− mice were obtained (Fig. S2A) and, when phenotyped, had normal
hematopoiesis (Table S1), organogenesis, fecundity, and longevity. CAIA was induced in
Gpsm3−/− mice and in age- and gender-matched wildtype controls. Gpsm3−/− mice had
significant decreases in paw swelling and clinical disease scores (Fig. 2A, B). The incidence
of disease was also reduced by GPSM3 deficiency to 34% compared to 95% in control mice
(data not shown). At experiment termination, histological sections were scored by a blinded
pathologist for the extent of inflammatory cell infiltration, cartilage erosion, synovial
hyperplasia, and periosteal erosion (Fig. 2C, D); the severity of inflammation and erosion
was reduced or absent in Gpsm3−/− mice compared to controls (Fig. 2E).
3.3 Gpsm3−/− arthritic paws have reduced expression of proinflammatory cytokines and
chemokine receptors
To analyze the expression of validated monocyte-derived proinflammatory mediators (11),
RNA was extracted from paws of CAIA mice at experiment termination and transcripts for
IL-1β, IL-6, and TNF-α were analyzed by qRT-PCR. IL-1β and IL-6 transcripts levels were
significantly reduced in inflamed paws from Gpsm3−/− mice (Fig. 2F), whereas TNF-α
transcripts were similar in both groups.
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Two major subsets of monocytes have been identified in mice based on their functional
properties and level of surface expression of the chemokine receptors CCR2 and CX3CR1
(14). Proinflammatory monocytes are recruited to the inflamed synovium by the action of
inflammation-driven chemokines such as Monocyte Chemoattractant Protein-1 (MCP-1 or
CCL2), the ligand for CCR2 (14, 16) and Fractalkine (FKN or CX3CL1), the ligand for
CX3CR1 (11). Real-time PCR analysis of CCR2 and CX3CR1 transcripts in arthritic paws
revealed that the expression levels of both were significantly reduced in Gpsm3−/− mice
(Fig. 2G).
3.4. Reduced number, viability, and chemotactic function of GPSM3-deficient myeloid cells
Monocytes characterized by the cell surface markers Ly6Chigh and CD11b+ are thought to
be proinflammatory in that they mobilize rapidly in response to infection and inflammation
(17). Flow cytometry of isolated splenocytes from Gpsm3−/− mice revealed that the
abundance of inflammatory monocytes, characterized by Ly6ChighCD11b+ expression was
significantly reduced in comparison to littermate control mice (Fig. 3A), whereas the
granulocyte Ly6G+ population was not significantly altered. Furthermore, monocytic THP-1
cells deficient in GPSM3 (6) were more sensitive to death induced by apoptotic stimuli (Fig.
3B), suggesting effects on viability.
Activation of the monocyte/macrophage system is a hallmark of rheumatoid arthritis (16);
such activation is potentiated in the CAIA model by LPS injection in vivo (18), allowing for
subsequent isolation of physiologically activated monocytes/macrophages (19). To analyze
the chemotactic responsiveness of mature, proinflammatory myeloid cells, Gpsm3−/− and
control mice were injected with LPS and resultant Ly6C-enriched/CD11b+ splenocytes were
tested for their migration ex vivo towards a panel of proinflammatory monocytic
chemokines. Ly6C-enriched/CD11b+ splenocytes from Gpsm3−/− mice had significantly
reduced chemotaxis toward CCL2/MCP-1, CX3CL1/FKN, and chemerin, although no
statistical differences were observed for CCL3/MIP-1α or CCL5/RANTES (Fig. 3C).
4. DISCUSSION
Monocytes are critical to autoimmune arthritis disease pathogenesis through their roles in
antigen presentation and production of pro-inflammatory cytokines (1, 2); in particular,
chemotaxis of circulating monocytes toward the inflamed joint, and their subsequent
differentiation into proinflammatory macrophages, is critical to the development and
exacerbation of RA (16). Our results support a key role of GPSM3 in monocyte function and
in disease pathogenesis in an acute inflammatory arthritis disease model–a finding that, in
turn, strengthens the association of human GPSM3 polymorphisms in autoimmune diseases
including RA and AS (8, 9). Part of the protection to CAIA conferred by GPSM3 deficiency
is believed to occur through altered chemotaxis toward multiple proinflammatory
chemokines that target monocytes to the synovium, which suggests that GPSM3 may be a
promiscuous regulator of multiple Gαi-coupled receptors. Additionally, impaired survival of
GPSM3-deficient monocytes upon exposure to pro-apoptotic stimuli may also affect overall
monocyte differentiation and function in vivo and, thus, the severity of disease sequelae.
These data provide compelling rationale for future studies examining GPSM3 deficiency in
chronic autoimmune models such as CIA, as well as an examination of GPSM3 gene
products and monocyte function in humans with and without autoimmune inflammatory
arthritis.
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• GPSM3 is highly expressed in mature monocytes.
• GPSM3-deficient monocytes have decreased chemotaxis to CCL2, CX3CL1,
and chemerin.
• GPSM3-deficient THP-1 cells have enhanced apoptosis.
• Gpsm3−/− mice have decreased arthritis in the Collagen Antibody Induced
Arthritis (CAIA) model.
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Figure 1. GPSM3 is most highly expressed in mature monocytes
(A) Bone marrow cells from C57Bl/6 mice were cultured on plastic; treatment over 9 days
with M-CSF (L-929 conditioned medium) induced upregulation of CD14 expression and
GPSM3 expression. (B) Differentiation of THP-1 cells into macrophages using PMA (50 ng/
mL) decreased GPSM3 protein and (C) mRNA expression over 72 hours. GPSM3 transcript
levels were normalized for relative expression levels using the 2-(ΔΔCt)method with 18S
rRNA as the internal control. Data is presented as percent relative expression compared to
the untreated (“zero hrs”) THP-1 cell line sample. (D) Endogenous GPSM3 expression was
detected by indirect immunofluorescence and confocal microscopy in THP-1 cells cultured
on poly-D-lysine-coated coverslips and treated with ethanol vehicle control (upper panels)
or 50 ng/mL PMA for 72 hours (lower panels). Arrowheads denote THP-1 cells with
macrophage-like morphology (less-rounded, extended processes). Scale-bar, 20 μm.
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Figure 2. Inflammatory signs of arthritis are reduced in Gpsm3−/− mice
All data are combined from two separate experiments (Gpsm3−/−, n=10; Gpsm3+/+, n=15).
(A) Mean clinical index over time (+/− SEM) was significantly reduced in Gpsm3−/− mice
(LRT = 6.5, df=2, p <0.05). (B) Mean difference in paw swelling from baseline thickness
over time (+/− SEM) was also significantly different (LRT = 13.5, df=3, p<0.01). (C, D)
Representative H&E histology of hind limbs at experiment termination (day 10) shows that
late stage inflammation and erosion are decreased in Gpsm3−/− mice. Arrows highlight
major inflammatory and erosive differences between genotypes. (E) Histological evaluation
of both hind paws were examined (day 10) and scored on a 0–4 scale for each subcategory.
Quantitative RT-PCR demonstrated a significant reduction in expression of transcripts for
the pro-inflammatory cytokines IL-6 and IL-1β (F) as well as the chemokine receptors
CCR2 and CX3CR1 (G) in Gpsm3−/− mice arthritic paws compared to wildtype controls.
Transcript levels were normalized for relative expression levels using the 2-(ΔΔCt) method
with IDUA rRNA as the internal control. Data is presented as percent relative expression
compared to a mouse paw without arthritis.
Giguère et al. Page 10













Figure 3. GPSM3-deficient splenocytes have decreased number and chemotactic function of the
Ly6C+CD11b+ myeloid population, and GPSM3-deficient myeloid THP-1 cells exhibit enhanced
apoptosis
(A) Flow cytometry analysis of splenocytes revealed decreased numbers of
Ly6ChighCD11b+ monocytes in Gpsm3−/− mice versus wildtype controls, while the
numbers of Ly6G+ granulocytes were not altered (n = 3; **, p < 0.05). (B) GPSM3-deficient
THP-1 cells (bearing stable expression of lentiviral-transduced shRNAs sh19 and sh20; (6))
have enhanced apoptosis in early (annexin V positive, propidium iodide negative) and late
(annexin V positive, propidium iodide positive) stages following etoposide treatment (n=3,
*p<0.05). (C) Migration in response to indicated chemokines was determined by anti-
CD11b staining and flow cytometry of migrated Ly6C+ enriched cells from LPS-treated
Gpsm3−/− mice vs littermate controls. Data are represented as percent migration of total
input (mean +/− SEM, n=6).
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